Updated: Jul 24, 2026

Peter Welford's Stock Ratings

Jefferies Analyst

Peter Welford is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.

Overall Average Return

8.27%

Smart Score

57.3%

Overall Average Return Percentile

53rd

Number of Ratings

13
Buy NowGet Alert
11/12/2024GSKBuy Now
GSK
$51.28DowngradeBuy → HoldGet Alert
09/03/2024NVSBuy Now
Novartis
$155.56DowngradeBuy → HoldGet Alert
07/02/2024NVSBuy Now
Novartis
$155.56-21.25%$121 → $122.5MaintainsBuyGet Alert
07/02/2024GSKBuy Now
GSK
$51.283.34%$52.5 → $53MaintainsBuyGet Alert
01/03/2024AZNBuy Now
AstraZeneca
$168.90DowngradeBuy → HoldGet Alert
01/03/2024GSKBuy Now
GSK
$51.28-6.41%$38.5 → $48UpgradeHold → BuyGet Alert
09/25/2023AZNBuy Now
AstraZeneca
$168.90-52.63%$66.5 → $80UpgradeHold → BuyGet Alert
01/23/2023GLPGBuy Now
Galapagos
$49 → $47.2UpgradeUnderperform → HoldGet Alert
12/07/2021AZNBuy Now
AstraZeneca
$168.90DowngradeBuy → HoldGet Alert
09/16/2021GMABBuy Now
Genmab
$28.83DowngradeBuy → HoldGet Alert
05/25/2021VACCBuy Now
Vaccitech
→ $28Initiates → BuyGet Alert
03/16/2021AZNBuy Now
AstraZeneca
$168.90UpgradeHold → BuyGet Alert
08/25/2020GLPGBuy Now
Galapagos
DowngradeBuy → HoldGet Alert